Figen Kaptan

Figen Kaptan

Auto-generated profile, based on publicly available information

Figen Kaptan

Izmir Katip Celebi Universty Ataturk Training and Research Hospital, Department of Infection Diseaeses and Clinical Microbiology, Izmir, Turkey

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2023 in International Journal of the Cardiovascular Academy
Verified
Journal Article
Closed access
BKBANU KARACA
BANU KARACA
FÇFahrettin Tuğrul Çitekçi
Fahrettin Tuğrul Çitekçi
BEBeyza Erol
Beyza Erol
BÖBahar Örmen
Bahar Örmen
NSNurbanu Sezak
Nurbanu Sezak
TKTuncay Kırış
Tuncay Kırış

1 May 2024 in Current HIV Research
Verified
Journal Article
Closed access
PDF file
ÖKÖzge Eren Korkmaz
Özge Eren Korkmaz
FAFigen Kaptan Aydoğmuş
Figen Kaptan Aydoğmuş
Introduction: The prevalence of sleep disorders in people living with HIV (PLWH) is higher than in the general population. Even if viral suppression is achieved with Antiretroviral Therapy (ART), the chronic immune activation and increased inflammation due to immune reconstitution persist. The aim of our study was to determine the prevalence of poor quality of sleep (QoS) and associated risk factors in PLWH and to investigate the relationship between poor QoS and CD4 T lymphocyte count and CD4 reconstitution. Methods: PLWH ≥18 years old, attending for routine HIV monitoring were recruited. PLWH with conditions that may affect their QoS (pregnant, hospitalized, malignancy, substance-alcohol abuse, psychiatric disease or treatment, sleeping pill) were excluded. Pittsburgh Sleep Quality Index (PSQI, score ≥5 indicates poor QoS), Epworth Sleepiness Scale (ESS, score ≥11 indicates daytime sleepiness), and Beck Depression Scale (BDS, score ≥10 indicates clinical depression) were applied. CD4+ T lymphocyte reconstitution (current-baseline CD4+ count) and CD4+ T lymphocyte reconstitution rate [(current-baseline CD4+ count)/duration of HIV infection in years] were calculated for PLWH on ART. Student t-test and Pearson’s chi-squared test were used for analysing the data, and p0,05). Daytime sleepiness in PLWH with poor Qos (p=0.04) was significantly increased (vs good QoS). Clinical depression (p=0.001) was significantly more common in PLWH with poor QoS (vs good QoS). Although statistically nonsignificant (p>0,05), younger age, female sex, being single, homosexüel sexual preference, high income and living with the family were associated with poor QoS. No association was found between the ART regime and QoS. PLWH with poor QoS had a higher CD4+ T lymphocyte count (p>0,05), a higher number of CD4+ T lymphocyte reconstitution (p<0.05), and a higher reconstitution rate than PLWH with good QoS (p<0.05). Conclusion: Prevalence of poor QoS was high in our cohort. Poor QoS was associated with CD4+ T lymphocyte reconstitution and reconstitution rate.

20 March 2025 in Flora the Journal of Infectious Diseases and Clinical Microbiology
Verified
Journal Article
Closed access
NTNesrin Türker
Nesrin Türker
BKBANU KARACA
BANU KARACA
HAHatice Burcu Açikalin Arikan
Hatice Burcu Açikalin Arikan
BÖBahar Örmen
Bahar Örmen
FKFigen Kaptan
Figen Kaptan
ÖKÖzge Eren Korkmaz
Özge Eren Korkmaz

27 December 2025 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
NTNesrin Türker
Nesrin Türker
ÖKÖzge Eren Korkmaz
Özge Eren Korkmaz
FAFigen Kaptan Aydogmus
Figen Kaptan Aydogmus
NGNur Miray Ayhan Geniş
Nur Miray Ayhan Geniş
TMTuba Müderris
Tuba Müderris
MAMurat Aksun
Murat Aksun

29 June 2024 in Klimik Dergisi/Klimik Journal
Verified
Journal Article
Open access
BÖBahar Örmen
Bahar Örmen
NTNesrin Türker
Nesrin Türker
BKBANU KARACA
BANU KARACA
İSİsmail Ertan Sevin
İsmail Ertan Sevin
RÖRamazan Özdemir
Ramazan Özdemir
BPBilal Olcay Peker
Bilal Olcay Peker
The risk of thromboembolic pathologies increases in COVID-19 cases who have risk factors for poor prognosis and are prone to have a severe clinical course. Few cases of cerebral sinus vein thrombosis (CSVT) accompanying COVID-19 have been reported. We present a patient who developed CSVT during COVID-19 without a known risk factor for thrombosis but was found to have a genetic mutation of the prothrombin 20210 G/A gene, which is a congenital thrombophilia risk factor. We aim to emphasize the importance of investigating additional pathologies in thromboembolic events during COVID-19 in cases without known comorbidities.

1 April 2026 in Current HIV Research
Verified
Journal Article
Closed access
PDF file
CHCigdem Ataman Hatipoglu
Cigdem Ataman Hatipoglu
SÜSerhat Ünal
Serhat Ünal
MKMeliha Meriç Koç
Meliha Meriç Koç
FAFigen Kaptan Aydoğmuş
Figen Kaptan Aydoğmuş
YBYasar Bayindir
Yasar Bayindir
SKSami Kınıklı
Sami Kınıklı
Objective: HIV testing procedure in the presence of HIV indicator conditions is considered an effective strategy to identify undiagnosed people living with HIV. We aimed in this study to evaluate HIV testing and diagnosis rates obtained via non-targeted testing in seven hospitals across Turkey, specifically focusing on patients with HIV indicator conditions. Methods: Data from a total of 3,371,188 patients with hospital admissions for various clinical conditions were analyzed in this retrospective multicenter cross-sectional study, which was carried out in seven hospitals within a 6-months period. HIV testing and HIV diagnosis rates were retrospectively evaluated in the overall population and in the subgroups of patients with and without HIV-indicator conditions. Results: Rates of HIV testing and positivity in the overall population of 3,371,188 patients screened across seven hospitals were 8.3% (281,321/3,371,188) and 0.2% (557/281,321), respectively. HIV testing and HIV positivity rates in 19,410 patients with HIV-indicator conditions were 11.5% (2,225/19,410) and 0.4% (9/2,225), respectively. HIV testing and HIV positivity rates in 3,351,778 patients without HIV-ICs were 8.3% (279,096/3,351,778) and 0.2% (548/279,096), respectively. The rate of HIV testing and HIV positivity in patients with HIV-ICs was statistically significantly higher than in the patients without HIV-ICs (p = 0.000 and p = 0.047, respectively). Discussion: Our findings revealed that only 11.5% of patients with HIV-indicating conditions underwent HIV testing, indicating that most patients are not timely diagnosed despite having HIV-indicating conditions, and these patients remain at risk of living with unknown HIV status. The utilization of testing outside the HIV-indicator conditions criteria in 8.3% of cases was also notable. The likelihood of a positive diagnosis rate was at least 2-fold increased when the screening was guided by HIV-indicator conditions. Conclusion: In conclusion, according to the study, HIV testing in patients with HIV-indicator conditions increased the rate of HIV diagnosis, but the rate of requesting testing in the presence of HIV indicator conditions was low. HIV testing practices among physicians in the Turkish healthcare settings should be improved with interventions for an improved awareness of HIVindicator conditions, guided HIV testing, and adopting the related guidelines to appropriately identify undiagnosed HIV cases.